File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.febslet.2006.04.080
- Scopus: eid_2-s2.0-33646556664
- PMID: 16696977
- WOS: WOS:000238107400034
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells
Title | Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells |
---|---|
Authors | |
Keywords | Endothelial cells Ginsenoside-Rg1 Glucocorticoid receptor Nitric oxide |
Issue Date | 2006 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/febslet |
Citation | Febs Letters, 2006, v. 580 n. 13, p. 3211-3216 How to Cite? |
Abstract | We here provide definitive evidence that ginsenoside-Rg1, the pharmacologically active component of ginseng, is a functional ligand of the glucocorticoid receptor (GR) as determined by fluorescence polarization assay. Rg1 increased the phosphorylation of GR, phosphatidylinositol-3 kinase (PI3K), Akt/PKB and endothelial nitric oxide synthase (eNOS) leading to increase nitric oxide (NO) production in human umbilical vein endothelial cell. Rg1-induced eNOS phosphorylation and NO production were significantly reduced by RU486, LY294,002, or SH-6. Also, knockdown of GR completely eliminated the Rg1-induced NO production. This study revealed that Rg1 can indeed serve as an agonist ligand for GR and the activated GR can induce rapid NO production from eNOS via the non-transcriptional PI3K/Akt pathway. © 2006 Federation of European Biochemical Societies. |
Persistent Identifier | http://hdl.handle.net/10722/169847 |
ISSN | 2023 Impact Factor: 3.0 2023 SCImago Journal Rankings: 1.208 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leung, KW | en_HK |
dc.contributor.author | Cheng, YK | en_HK |
dc.contributor.author | Mak, NK | en_HK |
dc.contributor.author | Chan, KKC | en_HK |
dc.contributor.author | David Fan, TP | en_HK |
dc.contributor.author | Wong, RNS | en_HK |
dc.date.accessioned | 2012-10-25T04:57:02Z | - |
dc.date.available | 2012-10-25T04:57:02Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | Febs Letters, 2006, v. 580 n. 13, p. 3211-3216 | en_HK |
dc.identifier.issn | 0014-5793 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/169847 | - |
dc.description.abstract | We here provide definitive evidence that ginsenoside-Rg1, the pharmacologically active component of ginseng, is a functional ligand of the glucocorticoid receptor (GR) as determined by fluorescence polarization assay. Rg1 increased the phosphorylation of GR, phosphatidylinositol-3 kinase (PI3K), Akt/PKB and endothelial nitric oxide synthase (eNOS) leading to increase nitric oxide (NO) production in human umbilical vein endothelial cell. Rg1-induced eNOS phosphorylation and NO production were significantly reduced by RU486, LY294,002, or SH-6. Also, knockdown of GR completely eliminated the Rg1-induced NO production. This study revealed that Rg1 can indeed serve as an agonist ligand for GR and the activated GR can induce rapid NO production from eNOS via the non-transcriptional PI3K/Akt pathway. © 2006 Federation of European Biochemical Societies. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/febslet | en_HK |
dc.relation.ispartof | FEBS Letters | en_HK |
dc.subject | Endothelial cells | en_HK |
dc.subject | Ginsenoside-Rg1 | en_HK |
dc.subject | Glucocorticoid receptor | en_HK |
dc.subject | Nitric oxide | en_HK |
dc.subject.mesh | Chromones - Pharmacology | en_US |
dc.subject.mesh | Endothelial Cells - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Enzyme Inhibitors - Pharmacology | en_US |
dc.subject.mesh | Ginsenosides - Metabolism - Pharmacology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Mifepristone - Pharmacology | en_US |
dc.subject.mesh | Morpholines - Pharmacology | en_US |
dc.subject.mesh | Nitric Oxide - Biosynthesis | en_US |
dc.subject.mesh | Nitric Oxide Synthase Type Iii - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Phosphatidylinositol 3-Kinases - Metabolism | en_US |
dc.subject.mesh | Phosphorylation | en_US |
dc.subject.mesh | Protein Transport - Drug Effects | en_US |
dc.subject.mesh | Proto-Oncogene Proteins C-Akt - Metabolism | en_US |
dc.subject.mesh | Receptors, Glucocorticoid - Agonists - Genetics - Metabolism | en_US |
dc.subject.mesh | Signal Transduction | en_US |
dc.title | Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Leung, KW: kwleung1@hku.hk | en_HK |
dc.identifier.authority | Leung, KW=rp01674 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.febslet.2006.04.080 | en_HK |
dc.identifier.pmid | 16696977 | - |
dc.identifier.scopus | eid_2-s2.0-33646556664 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33646556664&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 580 | en_HK |
dc.identifier.issue | 13 | en_HK |
dc.identifier.spage | 3211 | en_HK |
dc.identifier.epage | 3216 | en_HK |
dc.identifier.isi | WOS:000238107400034 | - |
dc.publisher.place | Netherlands | en_HK |
dc.identifier.scopusauthorid | Leung, KW=13106059300 | en_HK |
dc.identifier.scopusauthorid | Cheng, YK=9133925600 | en_HK |
dc.identifier.scopusauthorid | Mak, NK=35587830100 | en_HK |
dc.identifier.scopusauthorid | Chan, KKC=25633775800 | en_HK |
dc.identifier.scopusauthorid | David Fan, TP=13410504200 | en_HK |
dc.identifier.scopusauthorid | Wong, RNS=7402126957 | en_HK |
dc.identifier.issnl | 0014-5793 | - |